Co-Founder Disputes & Departure

Co-Founder Disputes & Departure

A "founder divorce" is emotionally draining, but without robust legal documentation, it becomes a terminal event for the startup.  Here are the top mistakes startup founders make at incorporation which can make a divorce costly:

  1. No Vesting Schedule: The most catastrophic failure occurs when a Restricted Stock Purchase Agreement (RSPA) lacks a clear vesting schedule. Without "time-based" or "milestone" vesting, a departing founder may walk away with 50% of the equity on Day 2, leaving the remaining team to do 100% of the work for 50% of the reward—a cap table "dead weight" that no VC will touch.

  2. No IP Assignment: Complications escalate when IP assignments are ambiguous. If the departing founder claims ownership of the core codebase because the assignment was "subject to" a condition that wasn't met or a CIIAA/PIIAA that was never signed, the company loses its "title" to the technology. 

  3. No Offer Letter: Furthermore, restrictive-covenant gaps usually arising from a startup’s failure to provide a founder with an Offer Letter and CIIAA/PIIAA may allow a disgruntled co-founder the opportunity to launch a direct competitor, poach key engineers, and leverage "insider" knowledge with total impunity.

  4. Board Deadlock: The ultimate gridlock is board deadlock where there are an even number of people on the Board, each with 1 vote.  In a 50/50 split with no tie-breaking mechanism or “shotgun” clause, the company enters a legal paralysis where it cannot raise capital, hire executives, or even file taxes, essentially dooming the venture to judicial dissolution.  Most of our clients never start a company with an even-numbered board.  If the startup only has two founders at incorporation, the startup often appoints a trusted third-party "independent" board member from Day 1, so that person can cast a vote in the event the two founders are at odds. This prevents deadlock from ever reaching a court and keeps the company moving even when the founders stop speaking.

The cost of litigation to "clean up" a messy exit is five times the cost of drafting proper papers at incorporation. Governance isn't about lack of trust; it's about insurance for the unexpected.

8. AI/ML Legal Risk (Vendor & User)

In 2026, AI enterprise contracting has shifted from "experimental" to "high-stakes risk allocation." Startups must approach contracts as a legal moat, balancing aggressive innovation with institutional-grade compliance.  Here are the top concerns we talk about with our startup clients:

  • Data and IP Governance: Warranting training data provenance is now a baseline requirement to prove your models aren't "toxic" or "copyright-contaminated" to satisfy the EU AI Act. Simultaneously, customer data use limits must be airtight—explicitly guaranteeing that client data will not be commingled or used to train global models without an opt-in private instance. Regarding output IP ownership, our startups use "contractual assignment" language to transfer rights to the buyer, while reserving a perpetual license to the underlying architectural patterns and prompts.

  • Liability and Workflow Security: To manage hallucination liability, contracts must include "Non-Determinism Disclaimers" and mandate a "Human-in-the-Loop" (HITL) review for consequential outputs, shifting the burden of accuracy back to the user. Internally, managing inbound AI tools in your dev workflow is critical; you must warrant to customers that AI-generated code snippets (e.g., from Copilot) haven't introduced "copyleft" viral licenses into your proprietary stack. By codifying these AI-specific reps, you transform legal overhead into a competitive advantage during enterprise procurement.


Most of our clients don't just sign a “standard” SaaS DPA.  As most of the clients here are currently AI enterprise SaaS/PaaS in 2026, most sign an AI-Specific Data Processing Addendum that defines exactly how model weights are treated during data deletion requests ("The Right to be Forgotten from the Model").

9. M&A Readiness — Consents & Gates

The exit landscape for startups before an IPO can entail a grueling Execution and Compliance Audit. Analyzing an acquisition offer requires a deep dive into the technicalities of your corporate structure and regulatory footprint.

1. The Governance Hurdle: Consents & Drags

  • A "Change-of-Control" (CoC) analysis is the first line of defense.  A startup must map every customer contract to determine if an acquisition triggers a termination right or requires Customer Consent (likely the latter). 

  • Simultaneously, a startup must audit any Drag-Along provisions in place to ensure your voting thresholds are calculated on an "as-converted" basis to prevent a single minority common shareholder from holding a potential sale hostage.

2. The Tax & Equity "Leakage"

  • Section 280G: If the deal involves "Golden Parachute" payments, the startup must perform a 280G analysis early with tax counsel. In 2026, the cost of the 20% excise tax on executives (and the lost corporate deduction) often leads to "cleansing votes" by shareholders to avoid the penalty.

  • ISO Disqualification: Founders considering an acquisition should be transparent with employees that cashing out Incentive Stock Options (ISOs) upon accelerated vesting in a cash deal constitutes a "disqualifying disposition." They will be taxed at ordinary income rates rather than long-term capital gains, which can lead to post-deal morale issues if not messaged correctly.

3. The Regulatory "Kill-Switch" (HSR & CFIUS)

  • HSR Act: At the time of this post (i.e., 2026), the "Size of Transaction" threshold for mandatory filing has increased to $133.9 million. If your deal exceeds this, expect a minimum 30-day "waiting period" that can stretch into months if the FTC issues a "Second Request."

  • CFIUS: If your startup handles "TID" (Technology, Infrastructure, or Data), especially in AI, a foreign buyer triggers a CFIUS review. In 2026, this is no longer optional; a "non-notified" transaction can be unwound by the U.S. government years after closing.

4. R&W Insurance: The New Standard

Oftentimes, Representations & Warranties (R&W) Insurance replaced traditional escrows in the large majority  of mid-market deals.

  • The Benefit: Sellers walk away with 100% of their cash at closing (minus a small retention), while the buyer looks to the insurer for any breaches.

  • The Catch: Insurers now perform "diligence on the diligence." If your IP or data-privacy records are messy, the insurer will issue a "Carve-out," forcing you back into a traditional, high-risk escrow for those specific items.

One thing that can be forgotten during the sale is the audit of Blue Sky filings. If the startup somehow missed state securities filings during your SAFE seed round, it will surface during the R&W insurance underwriting and could delay your closing by weeks.

10. Governance, Fiduciary Duties & Board Hygiene

In 2026, corporate governance is no longer just "paperwork"—it is the primary defense against deal-killing litigation. For an early-stage startup, navigating a venture raise or sale requires a rigorous audit of fiduciary hygiene.

The Conflict and Fairness Bar 

Board decisions involving conflicted director votes or related-party transactions (e.g., bridge loans from existing VCs or leases from founders) no longer enjoy the protection of the "Business Judgment Rule" by default. Instead, Delaware courts apply the "Entire Fairness" standard, shifting the burden to the board to prove the deal was objectively fair. To mitigate this, startups must utilize Special Committees of disinterested directors or "Majority of the Minority" shareholder votes to sanitize the process.

The Oversight and Documentation Trail

Weak Board meeting minutes and lack of documentation are a red flag for any sophisticated buyer. 

Under the Caremark/Marchand doctrines, boards have an active "duty to monitor" mission-critical risks—such as AI safety, data security, and regulatory compliance. If Board Meeting minutes fail to reflect active deliberation on these "essential compliance prongs," directors may face personal liability.  Note: We always recommend that if affordable, a company should consider purchasing Directors & Officers (D&O) insurance to pick up coverage in the event a director or officer is personally sued for negligence in his/her/their role(s).

Finally, in "down rounds" or exits where the common stock is wiped out (the Trados trap), the board must demonstrate that it prioritized the interests of the common stockholders over the liquidation preferences of the preferred, or risk a post-closing lawsuit that claws back the merger proceeds.

Smart startups anticipating a sale don't just record "the board met."  We advise company founders to ensure that meeting minutes (and corresponding paper trails in emails, Slacks, texts, etc.) robustly document the alternatives considered.  

Silence on the record could be interpreted as a lack of care; a robust paper trail is the only way to keep the "Entire Fairness" bogeyman at bay.